Beyond the Headlines: What Pfizer’s $495M Sciwind Deal Really Signals for the GLP-1 Supply Chain
When Pfizer announced it would pay up to $495 million to commercialize Sciwind Biosciences’ GLP-1 agonist ecnoglutide in China, most […]
China’s peptide cosmetics market is entering a period of rapid growth.
Although China’s polypeptide cosmetics market started relatively late, its unique market dynamism and rapidly iterating local innovations have made it
The boom in multi-billion dollar peptides is shifting: breakthroughs in synthetic technology and restructuring of the industrial ecosystem are the keys to the next wave of growth.
As polypeptide drugs, represented by GLP-1, expand their applications across numerous chronic diseases—such as diabetes, weight management, chronic kidney disease,
2026 Peptide Drug Industry: Three “Volcanoes” Erupting Simultaneously on the Demand Side
I. Why Polypeptides Must Be Discussed Today Over the past 12 months, the hottest pharmaceutical keyword in global capital markets
Analysis of the current status, competitive landscape, and future development trends and prospects of the pharmaceutical industry in the second half of 2026
Polypeptides are compounds formed by multiple amino acids linked through peptide bonds, typically consisting of 10 to 100 amino acids